Blinatumomab in Pediatric B-cell Acute Lymphoblastic Leukemia (ALL) With Minimal Residual Disease (MRD)
Conditions
- Pediatric ALL, B Cell
- Minimal Residual Disease
Interventions
- DRUG: Blinatumomab for Injection
Sponsor
Seoul National University Hospital
Collaborators